NewsBenzinga아타라 바이오테라퓨틱스, 최대 2억 달러 증권 공모, 발행 및 판매 관련 기본 증권신고서 제출 아타라 바이오테라퓨틱스, 최대 2억 달러 증권 공모, 발행 및 판매 관련 기본 증권신고서 제출 Benzinga 2026.11.10 22:05 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report